Related references
Note: Only part of the references are listed.Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy
Seraina von Moos et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Antigen presentation by Langerhans cells
Botond Z. Igyarto et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines
Sandra Scheiblhofer et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy
Menno A. Kiel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy
S. von Moos et al.
ALLERGY (2012)
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
Gabriela Senti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT)
J. Ring et al.
ALLERGY (2011)
Recombinant allergens: What does the future hold?
Rudolf Valenta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies
Louisa K. James et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Advances in transcutaneous vaccine delivery: Do all ways lead to Rome?
Suzanne M. Bal et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
Gabriela Senti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
Peter S. Creticos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Sublingual immunotherapy: A comprehensive review
Linda S. Cox et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies
N Mothes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial
MT Lima et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Share Paper
